跳至主要内容
临床试验/JPRN-jRCTs051180131
JPRN-jRCTs051180131已完成未知

Prospective clinical study on prevention of relapse after chronic subdural hematoma after traditional Chinese medicine. - CSDH kobe study

Matsumoto Hiroaki0 个研究点目标入组 145 人开始时间: 2019年3月18日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
145

研究概览

简要总结

Chronic subdural hematoma recurs in 10-33% of patients after surgery, and reoperation or repeated exacerbation of symptoms may lead to deterioration of ADL and serious complications. In this study, we showed that the Japanese traditional medicines Saireito and Goreisan were effective in preventing recurrence in postoperative patients with chronic subdural hematoma.

研究设计

研究类型
Interventional

入排标准

年龄范围
20age 至 ot applicable(—)
性别
All

入选标准

  • 1. Patients with chronic subdural hematoma.
  • 2. Patient who is an initial case.
  • 3. Patients who are over 20 years old.

排除标准

  • 1.Patients who have difficulty in taking traditional Chinese medicine.
  • 2.Patients who show marked decline in cognitive function and have difficulty in compliance with medication compliance (such as those with an MMSE score of 23 or less)
  • 3. Asymptomatic and bilateral chronic subdural bloodline patients
  • 4. Patients with severe renal dysfunction (creatinine clearance less than 30 mL / min etc.)
  • 5.Patients who could not carry out prescribed surgery
  • 6.Patients who have allergies of traditional Chinese medicine and herbal medicines (such as those with a history of hypokalemia)
  • 7.Patients who are considered inappropriate for inclusion in research

研究者

发起方
Matsumoto Hiroaki

相似试验